Robert Ziegler

Robert Ziegler is an Associate Principal Scientist at AstraZeneca, specializing in medicinal chemistry for oncology drug discovery, with a focus on the synthesis and design of various innovative molecules. They previously served as a Senior Scientist at AstraZeneca, where they led projects involving diverse oncological targets and utilized structure-based drug design. Ziegler holds a Ph.D. in Synthetic Organic Chemistry from Boston University, where they conducted research on antitumor natural products, and has also completed a postdoctoral study at MIT centered on continuous flow chemistry for anti-HIV pharmaceuticals. Their early career included a role as a Neuroscience Chemistry Intern at Pfizer and an undergraduate research position at William & Mary.